BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 1980660)

  • 1. [Effectiveness of various combination therapies in patients with coronary heart disease].
    Lehmann G; Reiniger G; Wolf H; Beyerle A; Rudolph W
    Herz; 1990 Dec; 15(6):399-409. PubMed ID: 1980660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
    Blasini R; Brügmann U; Reiniger G; Rudolph W
    Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equal anti-ischemic properties of isosorbide dinitrate plus verapamil and isosorbide dinitrate plus propranolol. A randomized, double-blind and crossover study.
    Silber S; Vogler A; Theisen K
    Z Kardiol; 1986; 75 Suppl 3():100-5. PubMed ID: 3541414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
    Brügmann U; Blasini R; Rudolph W
    Herz; 1984 Aug; 9(4):244-52. PubMed ID: 6434387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
    Reiniger G; Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination of anti-angina drugs].
    Silber S
    Z Kardiol; 1989; 78 Suppl 2():160-74; discussion 188-9. PubMed ID: 2573981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
    Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of coronary disease].
    Trenkwalder P; Lydtin H
    Dtsch Med Wochenschr; 1992 Jan; 117(1):37-8. PubMed ID: 1346102
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of symptomatic and asymptomatic myocardial ischemia using 120 mg delayed-action ISDN].
    Reiniger G; Lehmann G; Beyerle A; Wolf H; Rudolph W
    Herz; 1990 Aug; 15(4):259-65. PubMed ID: 2210597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina.
    Kawanishi DT; Reid CL; Gonzales A; O'Rourke RA; Rahimtoola SH
    Circulation; 1989 Dec; 80(6 Suppl):IV162-70. PubMed ID: 2574640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of vasodilators with calcium entry- and beta-blockers in patients with coronary heart disease.
    Stauch M; Haerer W; Henze E; Hermann T; Kohler J; Kress P; Adam WE
    Z Kardiol; 1986; 75 Suppl 3():106-11. PubMed ID: 3026101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
    Dorow P; Schiess W
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):419-22. PubMed ID: 6386704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative effect of anti-anginal drugs on myocardial ischemia in patient with effort angina: evaluation by ambulatory electrocardiographic monitoring].
    Suzuki Y
    Hokkaido Igaku Zasshi; 1991 Jul; 66(4):441-9. PubMed ID: 1680782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
    Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TTS-nitroglycerin and slow-release metoprolol: efficacy in patients with stable exercise-induced angina].
    Scardi S; Pandullo C; Pivotti F; Pollavini G
    G Ital Cardiol; 1985 May; 15(5):526-32. PubMed ID: 2865188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
    Floris B; Paoletti G; Pelizza L; Bertulla A; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.